根治性前列腺切除术男性患者报告结局问卷:现有工具的概念性综述
该综述检索PubMed、牛津大学患者报告结局测量组数据库及ICHOM网站,识别出7种前列腺癌特异性患者报告结局问卷,并依据Wilson和Cleary框架及心理测量学标准进行批判性评估。结果显示6/7问卷声称测量健康相关生活质量,但条目集中于泌尿和性症状/功能,其心理测量学证据不完整且质量参差,无一有证据支持可用于个体患者。
要点
- 7种前列腺癌特异性PRO问卷中6种声称测量健康相关生活质量,但条目集中于泌尿和性症状/功能。
- 这些问卷的心理测量学证据不完整且质量参差,无一有证据支持可用于个体患者水平。
- 若干问卷为泌尿和/或性症状/功能的测量提供了基础,但需进一步研究其他HRQL方面及个体水平应用。
核心结论
- 现有前列腺癌特异性PRO问卷的心理测量学证据不完整且质量参差,无一有证据支持可用于个体患者水平。
研究设计与样本
- 检索PubMed、牛津大学患者报告结局测量组报告与出版物数据库及ICHOM网站,寻找前列腺癌特异性PRO问卷的心理测量学综述,识别相关问卷并依据Wilson和Cleary框架及既定标准批判性评估概念内容和心理测量学特性。
- 检索到4篇综述和1篇推荐论文,识别出7种前列腺癌特异性PRO问卷:EPIC-26、EPIC-50、UCLA-PCI、FACT-P PCS、EORTC QLQ-PR25、PC-QoL和STAR。
主要发现
- 7种问卷中6种声称测量健康相关生活质量(HRQL),但条目强烈集中于泌尿和性症状/功能;剩余问卷STAR声称评估RP后功能恢复。
- 这些问卷的心理测量学证据不完整且质量参差;无一有证据表明其适用于个体患者。
临床怎么用
- 若干问卷为泌尿和/或性症状/功能的测量提供了基础。
- 作者认为进一步工作应探索对接受RP男性重要的其他HRQL方面,并需进一步心理测量学工作以确定能否在个体水平使用。
局限性
- 这些问卷的心理测量学证据不完整且质量参差;无一有证据表明其适用于个体患者。
- 作者指出进一步工作应探索其他HRQL方面,并需进一步心理测量学工作以确定能否在个体水平使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To critically review conceptual frameworks for available patient-reported outcome (PRO) questionnaires in men having radical prostatectomy (RP), psychometrically evaluate each questionnaire, and identify whether each is appropriate for use at the level of the individual patient. We searched PubMed, the Reports and Publications database of the University of Oxford Patient-Reported Outcomes Measurement Group and the website of the International Consortium for Health Outcomes Measurement (ICHOM) for psychometric reviews of prostate cancer-specific PRO questionnaires. From these we identified relevant questionnaires and critically appraised the conceptual content, guided by the Wilson and Cleary framework and psychometric properties, using well established criteria. The searches found four reviews and one recommendation paper. We identified seven prostate cancer-specific PROs: the Expanded Prostate Cancer Index Composite-26 (EPIC-26), Expanded Prostate Cancer Index Composite-50 (EPIC-50), University of California-Los Angeles Prostate Cancer Index (UCLA-PCI), Functional Assessment of Cancer Therapy - Prostate Cancer Subscale (FACT-P PCS), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - prostate specific 25-item (EORTC QLQ-PR25), Prostate Cancer - Quality of Life (PC-QoL), and Symptom Tracking and Reporting (STAR). Six out of seven measures purported to measure health-related quality of life (HRQL), but items focused strongly on urinary and sexual symptoms/functioning. The remaining questionnaire (STAR) claimed to assess functional recovery after RP. The psychometric evidence for these questionnaires was incomplete and variable in quality; none had evidence that they were appropriate for use with individual patients. Several questionnaires provide the basis of measures of urinary and/or sexual symptoms/functioning. Further work should explore other aspects of HRQL that are important for men having RP. Further psychometric work is also needed to determine whether they can be used at the individual level.
引用
- Protopapa E, van der Meulen J, Moore CM, et al. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments. BJU Int. 2017. PMID: 28437031. doi:10.1111/bju.13896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。